If you do continue treatment, no more than 300 mg of galcanezumab should be administered per month during the cluster period. After 3 weeks your doctor will decide if you should continue treatment. It should be started at the beginning of a cluster of headaches. To decrease the number of cluster headaches within a cluster period, the recommended dose is 300 mg (3 injections of 100 mg) injected subcutaneously once a month. It should not be used for the immediate treatment of migraines. Galcanezumab is intended to prevent migraines.

After the first dose, the regular dose is 120 mg injected subcutaneously once a month. To prevent migraines, the recommended starting dose of galcanezumab is 240 mg (2 injections of 120 mg each) injected subcutaneously (under the skin).

This medication is available in single-use pre-filled syringes or single use pre-filled pens for injection. Nonmedicinal ingredients: L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, sodium chloride, and water for injection. This medication is available in single-use pre-filled syringes.Įach 1 mL of sterile, preservative-free, clear, colourless-to-slightly-yellow solution contains 120 mg of galcanezumab. What form(s) does this medication come in?Įach 1 mL of sterile, preservative-free, clear, colourless-to-slightly-yellow solution contains 100 mg of galcanezumab. It can be harmful for people to take this medication if their doctor has not prescribed it. Do not stop taking this medication without consulting your doctor.ĭo not give this medication to anyone else, even if they have the same symptoms as you do. If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. As well, some forms of this medication may not be used for all of the conditions discussed here. Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here. This medication may be available under multiple brand names and/or in several different forms. Increased levels of this protein in the blood have been linked to migraines and episodic cluster headaches. This medication works by binding to the protein calcitonin gene-related peptide. It is also used to reduce the frequency of headaches during a period of cluster headaches, when other treatments to prevent cluster headaches have not worked, or have not been tolerated. It is used to prevent migraines for adults who experience at least 4 migraine days per month. Galcanezumab is a monoclonal antibody which belongs to the class of medications called calcitonin gene-related peptide (CGRP) antagonists. How does this medication work? What will it do for me?

Side effect of emgality